基于胱抑素C且不纳入种族和性别的肾小球滤过率估算方程
欧洲肾功能联盟(EKFC)基于瑞典227,643例患者数据估算胱抑素C的重新缩放因子,构建不包含种族和性别的EKFC eGFRcys方程,并在欧洲、美国和非洲的白人和黑人队列中验证。该方程无偏倚,准确性类似EKFC eGFRcr,优于KDIGO推荐的CKD-EPI eGFRcys方程;EKFC eGFRcr与eGFRcys的算术平均值进一步提高了准确性。
要点
- 在瑞典227,643例患者中估算胱抑素C重新缩放因子:小于50岁男女均为0.83,50岁及以上为0.83+0.005×(年龄-50)。
- EKFC eGFRcys方程在白人和黑人患者中无偏倚,准确性类似EKFC eGFRcr方程。
- EKFC eGFRcys方程准确性优于KDIGO推荐的CKD-EPI eGFRcys方程;两方程算术平均值进一步提高准确性。
核心结论
- EKFC eGFRcys方程与EKFC eGFRcr方程数学形式相同,但胱抑素C的缩放因子不因种族或性别而异。
- 在欧洲、美国和非洲队列中,该方程较常用方程提高了GFR评估的准确性。
研究设计与样本
- 使用瑞典患者数据估算成人胱抑素C的重新缩放因子。
- 将EKFC eGFRcr方程中重新缩放的血清肌酐替换为重新缩放的胱抑素C,构建EKFC eGFRcys方程。
- 在欧洲、美国和非洲的白人及黑人患者队列中,按实测GFR、血清肌酐和胱抑素C水平、年龄和性别验证方程。
主要发现
- 基于瑞典227,643例患者数据,胱抑素C重新缩放因子在小于50岁男性和女性均为0.83,在50岁及以上为0.83+0.005×(年龄-50)。
- EKFC eGFRcys方程无偏倚,在白人和黑人患者中准确性类似EKFC eGFRcr方程(欧洲11,231例、美国1,093例、非洲508例)。
- EKFC eGFRcys方程准确性优于KDIGO推荐的CKD-EPI eGFRcys方程。
- EKFC eGFRcr与EKFC eGFRcys的算术平均值较任一生物标志物方程单独估算进一步提高了准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The accuracy of estimation of kidney function with the use of routine metabolic tests, such as measurement of the serum creatinine level, has been controversial. The European Kidney Function Consortium (EKFC) developed a creatinine-based equation (EKFC eGFRcr) to estimate the glomerular filtration rate (GFR) with a rescaled serum creatinine level (i.e., the serum creatinine level is divided by the median serum creatinine level among healthy persons to control for variation related to differences in age, sex, or race). Whether a cystatin C-based EKFC equation would increase the accuracy of estimated GFR is unknown. METHODS: We used data from patients in Sweden to estimate the rescaling factor for the cystatin C level in adults. We then replaced rescaled serum creatinine in the EKFC eGFRcr equation with rescaled cystatin C, and we validated the resulting EKFC eGFRcys equation in cohorts of White patients and Black patients in Europe, the United States, and Africa, according to measured GFR, levels of serum creatinine and cystatin C, age, and sex. RESULTS: On the basis of data from 227,643 patients in Sweden, the rescaling factor for cystatin C was estimated at 0.83 for men and women younger than 50 years of age and 0.83 + 0.005 × (age - 50) for those 50 years of age or older. The EKFC eGFRcys equation was unbiased, had accuracy that was similar to that of the EKFC eGFRcr equation in both White patients and Black patients (11,231 patients from Europe, 1093 from the United States, and 508 from Africa), and was more accurate than the Chronic Kidney Disease Epidemiology Collaboration eGFRcys equation recommended by Kidney Disease: Improving Global Outcomes. The arithmetic mean of EKFC eGFRcr and EKFC eGFRcys further improved the accuracy of estimated GFR over estimates from either biomarker equation alone. CONCLUSIONS: The EKFC eGFRcys equation had the same mathematical form as the EKFC eGFRcr equation, but it had a scaling factor for cystatin C that did not differ according to race or sex. In cohorts from Europe, the United States, and Africa, this equation improved the accuracy of GFR assessment over that of commonly used equations. (Funded by the Swedish Research Council.).
引用
- Pottel H, Björk J, Rule AD, et al. Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex. N Engl J Med. 2023. PMID: 36720134. doi:10.1056/NEJMoa2203769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。